Department of Medicine III, Klinikum Krollwitz, Martin Luther University
Halle, Saxony-Anhalt, 06120, Germany
NCT Number: NCT00469248
The role of intra aortic balloon counterpulsation in patients experiencing acute myocardial infarction with shock is not established. We hypothesised that use of such a device would lead to improved outcomes in these patients.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Halle, Saxony-Anhalt, 06120, Germany
Patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) with cardiogenic shock (CS) are often treated with Intra-aortic balloon pump counterpulsation (IABP) although the evidence to support this is limited. We conducted a prospective, randomised clinical trial, of IABP as an addition to PCI centred therapy, in patients with AMI complicated by CS.
45 patients with AMI and CS undergoing PCI were randomised to care with or without IABP. Over 4 days, APACHE II scores, haemodynamic parameters, inflammatory markers and BNP levels were collected to assess the impact of IABP treatment on CS triggered multi organ dysfunction syndrome (MODS).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 4 days
Time frame: 4 days
Time frame: 4 days
Time frame: 4 days
Time frame: 4 days
Martin-Luther-Universität Halle-Wittenberg
Other
Intra-Aortic Balloon Counterpulsation in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock - The Prospective, Randomised IABP SHOCK Trial for Attenuation of Multi-Organ Dysfunction Syndrome
Acronym: IABPSHOCK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00324766
Cardiogenic Shock, Cardiovascular Diseases
Oslo, Norway
View Trial DetailsNCT05168462
Cardiogenic Shock, Cardiovascular Diseases
Amsterdam, Netherlands
View Trial DetailsNCT06955936
Cardiogenic Shock, Cardiovascular Diseases
Tomsk, Russia
View Trial DetailsNCT00491036
Cardiovascular Diseases, Heart Diseases
Bad Berka, Germany
View Trial Details